These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 21822301)
21. MicroRNA-937 inhibits cell proliferation and metastasis in gastric cancer cells by downregulating FOXL2. Yu L; Chen J; Liu Y; Zhang Z; Duan S Cancer Biomark; 2017 Dec; 21(1):105-116. PubMed ID: 29060929 [TBL] [Abstract][Full Text] [Related]
22. MiR-129-5p functions as a tumor suppressor in gastric cancer progression through targeting ADAM9. Liu Q; Jiang J; Fu Y; Liu T; Yu Y; Zhang X Biomed Pharmacother; 2018 Sep; 105():420-427. PubMed ID: 29879625 [TBL] [Abstract][Full Text] [Related]
23. miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression. Xie J; Chen M; Zhou J; Mo MS; Zhu LH; Liu YP; Gui QJ; Zhang L; Li GQ Oncol Rep; 2014 Apr; 31(4):1715-22. PubMed ID: 24573489 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer. Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864 [TBL] [Abstract][Full Text] [Related]
25. microRNA-665 is down-regulated in gastric cancer and inhibits proliferation, invasion, and EMT by targeting PPP2R2A. Zhang M; Wang S; Yi A; Qiao Y Cell Biochem Funct; 2020 Jun; 38(4):409-418. PubMed ID: 31923339 [TBL] [Abstract][Full Text] [Related]
26. Downregulation miR-539 is associated with poor prognosis of gastric cancer patients and aggressive progression of gastric cancer cells. Jin W; Han H; Liu D Cancer Biomark; 2019; 26(2):183-191. PubMed ID: 31403943 [TBL] [Abstract][Full Text] [Related]
27. [MiR-126 inhibits the proliferation and invasion of gastric cancer by downregulation of IGF-1R]. Wang H; Wang G; Tian WL Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):508-515. PubMed ID: 31357837 [No Abstract] [Full Text] [Related]
28. miR-3196 acts as a Tumor Suppressor and Predicts Survival Outcomes in Patients With Gastric Cancer. Chen G; Wan J; Wang Z; Li L; Jia H; Xing S; Chen S; Fan X; Li R Technol Cancer Res Treat; 2020; 19():1533033820923427. PubMed ID: 32419651 [TBL] [Abstract][Full Text] [Related]
29. SP1-activated long noncoding RNA lncRNA GCMA functions as a competing endogenous RNA to promote tumor metastasis by sponging miR-124 and miR-34a in gastric cancer. Tian Y; Ma R; Sun Y; Liu H; Zhang H; Sun Y; Liu L; Li Y; Song L; Gao P Oncogene; 2020 Jun; 39(25):4854-4868. PubMed ID: 32439864 [TBL] [Abstract][Full Text] [Related]
30. microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1. Zheng L; Qi T; Yang D; Qi M; Li D; Xiang X; Huang K; Tong Q PLoS One; 2013; 8(1):e55719. PubMed ID: 23383271 [TBL] [Abstract][Full Text] [Related]
31. Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1. Bae IH; Park MJ; Yoon SH; Kang SW; Lee SS; Choi KM; Um HD Cancer Res; 2006 May; 66(10):4991-5. PubMed ID: 16707418 [TBL] [Abstract][Full Text] [Related]
32. Clinicopathological significance of microRNA-214 in gastric cancer and its effect on cell biological behaviour. Wang YW; Shi DB; Chen X; Gao C; Gao P PLoS One; 2014; 9(3):e91307. PubMed ID: 24614175 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA‑34a attenuates the proliferation, invasion and metastasis of gastric cancer cells via downregulation of MET. Wei B; Huang QY; Huang SR; Mai W; Zhong XG Mol Med Rep; 2015 Oct; 12(4):5255-61. PubMed ID: 26238271 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-137 Contributes to Dampened Tumorigenesis in Human Gastric Cancer by Targeting AKT2. Wu L; Chen J; Ding C; Wei S; Zhu Y; Yang W; Zhang X; Wei X; Han D PLoS One; 2015; 10(6):e0130124. PubMed ID: 26102366 [TBL] [Abstract][Full Text] [Related]
35. sMicroRNA-28-5p acts as a metastasis suppressor in gastric cancer by targeting Nrf2. Yue CF; Li LS; Ai L; Deng JK; Guo YM Exp Cell Res; 2021 May; 402(2):112553. PubMed ID: 33737068 [TBL] [Abstract][Full Text] [Related]
36. miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression. Tang H; Deng M; Tang Y; Xie X; Guo J; Kong Y; Ye F; Su Q; Xie X Clin Cancer Res; 2013 Oct; 19(20):5602-12. PubMed ID: 23995857 [TBL] [Abstract][Full Text] [Related]
37. MiR-181d inhibits cell proliferation and metastasis through PI3K/AKT pathway in gastric cancer. Jiang K; Xie LF; Xiao TZ; Qiu MY; Wang WL Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8861-8869. PubMed ID: 31696473 [TBL] [Abstract][Full Text] [Related]
38. Down-regulation of miR-326 is associated with poor prognosis and promotes growth and metastasis by targeting FSCN1 in gastric cancer. Li Y; Gao Y; Xu Y; Ma H; Yang M Growth Factors; 2015; 33(4):267-74. PubMed ID: 26359764 [TBL] [Abstract][Full Text] [Related]
39. MiR-643 Functions as a Potential Tumor Suppressor in Gastric Cancer by Inhibiting Cell Proliferation and Invasion Wu Y; Ye H; Peng B; Jiang H; Tang Q; Liu Y; Xi J; Chen S Ann Clin Lab Sci; 2021 Jul; 51(4):494-502. PubMed ID: 34452887 [TBL] [Abstract][Full Text] [Related]
40. Human telomerase reverse transcriptase (hTERT) synergistic with Sp1 upregulate Gli1 expression and increase gastric cancer invasion and metastasis. Wu L; Wang S; Tang B; Tang L; Lei Y; Liu Y; Yang M; Yang G; Zhang D; Liu E J Mol Histol; 2021 Dec; 52(6):1165-1175. PubMed ID: 34601664 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]